首页> 外文期刊>Radiation oncology >The application of PET-CT to post-mastectomy regional radiation therapy using a deformable image registration
【24h】

The application of PET-CT to post-mastectomy regional radiation therapy using a deformable image registration

机译:PET-CT在可变形图像配准在乳房切除术后局部放射治疗中的应用

获取原文
           

摘要

Background To evaluate the utility of the preoperative PET-CT using deformable image registration (DIR) in the treatment of patients with locally advanced breast cancer and to find appropriate radiotherapy technique for further adequate treatment of axillary nodal area. Methods Sixty-five breast cancer patients who had level II, III axillary or supraclavicular lymph node metastasis on 18F-FDG PET-CT and received postoperative radiotherapy after modified radical mastectomy were enrolled. One radiation oncologist contoured normal organs (axillary vessels, clavicular head, coracoids process and humeral head) and involved lymph nodes on PET-CT and simulation CT slices. After contouring, deformable image registration of PET-CT on simulation CT was carried out. To evaluate the performance of the DIR, Dice similarity coefficient (DSC) and Center of mass (COM) were used. We created two plans, one was the historically designed three field plan and the other was the modified plan based on the location of axillary lymph node, and we compared the doses that irradiated the axillary lymph nodes. Results The DSCs for axillary artery, axillary vein, clavicular head, coracoids process and humeral head were 0.43?±?0.15, 0.39?±?0.20, 0.85?±?0.10, 0.72?±?0.20 and 0.77?±?0.20, respectively. The distances between the COMs of axillary artery, axillary vein, clavicular head, coracoids process and humeral head in simulation CT and from PET-CT were 13.0 ±7.1, 20.2?±?11.2, 4.4?±?6.3, 3.7?±?6.7, and 9.5?±?25.0?mm, respectively. In the historically designed plan, only 57.7% of level II lymph nodes received more than 95% of prescribed dose and the coverage was improved to 70.0% with the modified plan (p?
机译:背景技术为了评估术前使用可变形图像配准(DIR)进行PET-CT在治疗局部晚期乳腺癌患者中的效用,并找到适当的放射治疗技术来进一步适当治疗腋窝淋巴结区域。方法纳入65例乳腺癌患者,这些患者经18F-FDG PET-CT检查具有Ⅱ,Ⅲ级腋窝或锁骨上淋巴结转移,并在改良根治性乳房切除术后接受了放射治疗。一名放射肿瘤学家勾勒出正常器官(腋下血管,锁骨头,喙突和肱骨头)的轮廓,并在PET-CT和模拟CT切片上累及淋巴结。轮廓绘制后,在模拟CT上进行PET-CT的可变形图像配准。为了评估DIR的性能,使用了Dice相似系数(DSC)和质心(COM)。我们创建了两个计划,一个是根据历史设计的三个野外计划,另一个是根据腋窝淋巴结的位置进行的修改后的计划,并且我们比较了照射腋窝淋巴结的剂量。结果腋动脉,腋静脉,锁骨头,喙突和肱骨头的DSC分别为0.43±±0.15、0.39±±0.20、0.85±±0.10、0.72±±0.20和0.77±±0.20 。在模拟CT和PET-CT中,腋动脉,腋静脉,锁骨头,喙突和肱骨头的COM距离为13.0±7.1、20.2±±11.2、4.4±±6.3、3.7±6.7 ,分别为9.5?±?25.0?mm。在历史上设计的计划中,只有57.7%的II级淋巴结接受了超过95%的处方剂量,修改后的计划将覆盖率提高到70.0%(p <0.01)。对于III级淋巴结,在两个计划中接受的剂量超过规定剂量的95%是相似的(96.8%vs 97.9%,p = 0.35)。结论PET-CT在模拟CT上的可变形图像配准有助于确定术前受累腋窝淋巴结的位置。历史上设计的三视野计划不足以治疗腋窝II级淋巴结区域。基于DIR的PET-CT腋窝淋巴结定位的新治疗技术可导致更充分的淋巴结覆盖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号